Pharmaceuticals · SOUTH SAN FRANCISCO, CA, United States
$77.09
-0.28% (-$0.22)2026-08-24
Smart-Money SignalDistribution · 42/100— Insiders are net sellers over 90 days (-$9.2M, 42 sales vs 27 buys)
Revenue$28.6M
Net Income-$198.8M
EPS$-3.17
Market Cap$10.7B
Price Performance
Historical data including institutional events
Company Profile
R
Robert Blum
CEO & Executive Director
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
